Filing Details
- Accession Number:
- 0001645627-17-000051
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-05-04 11:57:11
- Reporting Period:
- 2017-05-01
- Filing Date:
- 2017-05-04
- Accepted Time:
- 2017-05-04 11:57:11
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1528172 | Endonovo Therapeutics Inc. | ENDV | Pharmaceutical Preparations (2834) | 452552528 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1645627 | Scott Michael Mann | 6320 Canoga Avenue Woodland Hills CA 91367 | President | No | Yes | Yes | No |
Transaction Summary
| Purchased: | 28,000 shares | Avg. Price: $0.08 | Total Value: $2,350.00 |
| Number of Shares After Transactions: | 20,549,949 shares | ||
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2017-05-01 | 1,000 | $0.09 | 20,522,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-01 | 1,000 | $0.09 | 20,523,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-01 | 1,000 | $0.09 | 20,524,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-01 | 1,000 | $0.09 | 20,525,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-01 | 1,000 | $0.09 | 20,526,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-01 | 1,000 | $0.09 | 20,527,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-01 | 1,000 | $0.09 | 20,528,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-01 | 1,000 | $0.09 | 20,529,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-01 | 1,000 | $0.08 | 20,530,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-01 | 1,000 | $0.08 | 20,531,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-01 | 1,000 | $0.08 | 20,532,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-01 | 1,000 | $0.08 | 20,533,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-01 | 1,000 | $0.08 | 20,534,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-01 | 1,000 | $0.09 | 20,535,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-01 | 1,000 | $0.09 | 20,536,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-02 | 1,000 | $0.08 | 20,537,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-02 | 1,000 | $0.08 | 20,538,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-02 | 1,000 | $0.08 | 20,539,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-02 | 1,000 | $0.08 | 20,540,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-02 | 1,000 | $0.08 | 20,541,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-02 | 1,000 | $0.08 | 20,542,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-02 | 1,000 | $0.08 | 20,543,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-02 | 1,000 | $0.08 | 20,544,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-02 | 1,000 | $0.08 | 20,545,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-02 | 500 | $0.08 | 20,546,449 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-02 | 500 | $0.08 | 20,546,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-02 | 1,000 | $0.08 | 20,547,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-02 | 1,000 | $0.08 | 20,548,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-02 | 1,000 | $0.08 | 20,549,949 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct |
Billionaire Hedge Funds
